The Food and Drug Administration (FDA) is not singling out Indian pharma companies, but insists the regulations in this regard are strictly followed, a top American drug official has said.
In its latest action against Indian drug makers, the US health regulator FDA had red- flagged "significant deviations" from good manufacturing practices by two Indian pharmaceutical companies: Hyderabad-based Posh Chemicals and Himachal Pradesh-based Sentiss Pharma (formerly Promed Exports).
FDA has a special focus on India given that it ranks number two in pharmaceuticals trade with the US, and that 40 percent of the over the counter prescription drug comes from India, US FDA India Office Director, Altaf A Lal, said. Read more
